Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2021 | Highlights from SABCS 2021

Michael Gnant • 8 Dec 2021
SABCS 2021
Breast Cancer

Michael Gnant, MD, Medical University of Vienna, Vienna, Austria, discusses the San Antonio Breast Cancer Symposium including updates on key clinical trials in breast cancer, as well as advances in the use of molecular profiling for the management of patients with breast cancer. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

More from Michael Gnant

Tailoring endocrine therapy: risk-based strategies and symptom management in HR+ breast cancer
6:03
Tailoring endocrine therapy: risk-based strategies and symptom management in HR+ breast cancer
Michael Gnant • 31 May 2025
Analyzing the findings of the SERENA-6 trial and its implications in the clinic
1:52
Analyzing the findings of the SERENA-6 trial and its implications in the clinic
Michael Gnant • 2 Jun 2025
What is the role of CDK4/6 inhibitors in early breast cancer?
5:07
What is the role of CDK4/6 inhibitors in early breast cancer?
Michael Gnant • 6 Jun 2023
NeoALTTO: HER2/CEP17 ratio as a predictive biomarker in HER+ breast cancer
2:27
NeoALTTO: HER2/CEP17 ratio as a predictive biomarker in HER+ breast cancer
Michael Gnant • 8 Jun 2023

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026
The content of VJOncology is intended for healthcare professionals